Literature DB >> 28971864

Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.

Kathleen Chiotos1,2,3, Pranita D Tamma4, Kelly B Flett5, Matthew Naumann4, Manjiree V Karandikar5, Warren B Bilker6,7, Theoklis Zaoutis8,3,6,7, Jennifer H Han6,7,9.   

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE) are increasingly identified in children in the United States, but data on the epidemiology of CRE in this population are limited. The objectives of this study were to characterize the risk factors for colonization or infection with CRE and describe the microbiologic characteristics of pediatric CRE isolates. We performed a multicenter matched case-control study from January 2011 to October 2015 at three tertiary care pediatric centers. Case patients were hospitalized children with CRE isolated from clinical cultures and were matched in a 2:1 ratio to control patients with carbapenem-susceptible Enterobacteriaceae (CSE). Risk factors for colonization or infection with CRE were then evaluated using a multivariable conditional logistic regression. Additionally, we comprehensively reported the antimicrobial susceptibility pattern for CRE isolates. Sixty-three case patients were identified and matched to 126 control patients. On multivariable analysis, antipseudomonal antibiotic exposure within the previous 3 months (odds ratio [OR], 5.20; 95% confidence interval [CI], 1.71 to 15.9; P = 0.004), prior surgery (OR, 6.30; 95% CI, 1.83 to 21.6; P = 0.003), and mechanical ventilation (OR, 12.4; 95% CI, 1.26 to 122; P = 0.031) were identified as risk factors for colonization or infection with CRE. Pediatric CRE isolates demonstrated relatively low rates of resistance to amikacin (5%) and ciprofloxacin (25%). Our findings support an important role for antibiotic stewardship interventions limiting the unnecessary use of antipseudomonal antibiotics as a strategy to prevent widespread emergence of CRE in children. Future studies should further characterize molecular determinants of antibiotic resistance among pediatric CRE isolates.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Gram-negative resistance; Klebsiella pneumoniae carbapenemase; multidrug-resistant organism; pediatrics

Mesh:

Substances:

Year:  2017        PMID: 28971864      PMCID: PMC5700345          DOI: 10.1128/AAC.01440-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program.

Authors:  Robyn M Kaiser; Mariana Castanheira; Ronald N Jones; Fred Tenover; Ruth Lynfield
Journal:  Diagn Microbiol Infect Dis       Date:  2013-05-06       Impact factor: 2.803

2.  Comparison of 11 Phenotypic Assays for Accurate Detection of Carbapenemase-Producing Enterobacteriaceae.

Authors:  Pranita D Tamma; Belita N A Opene; Andrew Gluck; Krizia K Chambers; Karen C Carroll; Patricia J Simner
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

3.  Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.

Authors:  Sara Colombo; Carlo Scolfaro; Carmelina Calitri; Marco Denina; Francesca Carraro; Gianfranco De Intinis; Pier-Angelo Tovo
Journal:  Infect Control Hosp Epidemiol       Date:  2014-05       Impact factor: 3.254

4.  Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.

Authors:  Todd A Davies; Anne Marie Queenan; Brian J Morrow; Wenchi Shang; Karen Amsler; Wenping He; A Simon Lynch; Chris Pillar; Robert K Flamm
Journal:  J Antimicrob Chemother       Date:  2011-07-20       Impact factor: 5.790

5.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia.

Authors:  Alejandro Díaz; Diana Cristina Ortiz; Mónica Trujillo; Carlos Garcés; Fabian Jaimes; Andrea Victoria Restrepo
Journal:  Pediatr Infect Dis J       Date:  2016-03       Impact factor: 2.129

7.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

8.  Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Authors:  Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

9.  A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.

Authors:  Saswati Datta; Subhasree Roy; Somdatta Chatterjee; Anindya Saha; Barsha Sen; Titir Pal; Tapas Som; Sulagna Basu
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

10.  Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.

Authors:  Latania K Logan; John P Renschler; Sumanth Gandra; Robert A Weinstein; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

View more
  18 in total

1.  Frequency of and risk factors for carbapenem-resistant Enterobacteriaceae.

Authors:  Katie E Barber; Jamie L Wagner; Rachel C Larry; Kayla R Stover
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

Review 2.  Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.

Authors:  Kathleen Chiotos; Molly Hayes; Jeffrey S Gerber; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

Review 3.  Carbapenem-Resistant Gram-Negative Bacterial Infections in Children.

Authors:  David Aguilera-Alonso; Luis Escosa-García; Jesús Saavedra-Lozano; Emilia Cercenado; Fernando Baquero-Artigao
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Risk factors for the colonization or infection of carbapenem-resistant Enterobacteriaceae in children: a Meta analysis.

Authors:  Bi-Yu Lin; Jing-Ting Liu; Feng-Ling Jin
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

5.  Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients.

Authors:  Jiansheng Wang; Yuanpeng Lv; Weiwei Yang; Peng Zhao; Changfu Yin
Journal:  BMC Microbiol       Date:  2022-07-12       Impact factor: 4.465

6.  A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.

Authors:  Latania K Logan; David C Nguyen; Felicia A Scaggs Huang; Nadia K Qureshi; Angella Charnot-Katsikas; Allison H Bartlett; Xiaotian Zheng; Andrea M Hujer; T Nicholas Domitrovic; Steven H Marshall; Robert A Bonomo; Robert A Weinstein
Journal:  Pediatr Infect Dis J       Date:  2019-05       Impact factor: 2.129

7.  A New Suite of Allelic-Exchange Vectors for the Scarless Modification of Proteobacterial Genomes.

Authors:  Jacob E Lazarus; Alyson R Warr; Carole J Kuehl; Rachel T Giorgio; Brigid M Davis; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2019-08-01       Impact factor: 4.792

8.  Antibiotic-Associated Adverse Events in Hospitalized Children.

Authors:  Rebecca G Same; Alice J Hsu; Sara E Cosgrove; Eili Y Klein; Joe Amoah; Adam L Hersh; Matthew P Kronman; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2021-05-28       Impact factor: 3.164

Review 9.  Optimal Management of Complicated Infections in the Pediatric Patient: The Role and Utility of Ceftazidime/Avibactam.

Authors:  Matteo Bassetti; Maddalena Peghin; Alessio Mesini; Elio Castagnola
Journal:  Infect Drug Resist       Date:  2020-06-12       Impact factor: 4.003

10.  Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

Authors:  Qun Lin; Yue Wang; Jing Yu; Shusheng Li; Yicheng Zhang; Hui Wang; Xiaoquan Lai; Dong Liu; Liyan Mao; Ying Luo; Guoxing Tang; Zhongju Chen; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.